{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68.9"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"49"}],"units":"Participants"}],"description":"-Progression is defined using Response Evaluation Criteria in Solid Tumors (RECIST 1.0) as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions.","groups":[{"description":"CTV1 = 66 Gy in 33 fractions\n\nCTV2 = 60 Gy in 33 fractions\n\nCTV3 = 56 Gy in 33 fractions\n\nCTV3 Proto = 56 Gy in 33 fractions","id":"OG000","title":"Arm 1: IMRT"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"3 years","title":"Kaplan Meier Estimate of Progression-free Survival","type":"POST_HOC","unitOfMeasure":"percentage of participants-Kaplan Meier"}